Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Identify a reliable starting point by focusing on liquidity, security, and real-world use cases that resonate with new investors.
23,504 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A major tax package for seniors is nudging Social Security funding timelines earlier, prompting fresh debate among re...
Leaders are navigating a three-way test: grow economies, protect energy security, and push for sustainability. This b...
JB Straubel’s initial pitch to Elon Musk missed the mark on aviation, but his pivot to electric cars launched Tesla t...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
Markets show a three-way dance: oil slides, gold falters, and stocks barely move as Alphabet makes its Dow debut. Her...
The chatter around a SpaceX IPO has investors buzzing, but hype can blur fundamentals. This guide breaks down what to...
The Federal Reserve’s 2026 annual stress test finds the largest U.S. banks would weather a sharp downturn without fai...
HomeServices of America and Douglas Elliman scored legal wins this week as they push forward with nationwide homebuye...
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
Super Micro Computer is moving past a volatile year as AI server demand surges. A new stock price prediction: super s...
Markets confront a rebalanced risk outlook as Iran signals it may push for nuclear concessions to survive. Investors ...